Go to article: Home | Advancing islet transplantation for type 1 diabetesGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Endress+HauserGo to article: Dr. Paul LohmannGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: NiproGo to article: Bio Image SystemsGo to article: In DepthGo to article: Islet transplantation for type 1 diabetes: Do regulators have it right?Go to article: DCT Tracker: Are sponsors getting better at conducting DCTs? Go to article: Why are haemophilia gene therapies so expensive? Go to article: Non-viral vectors could alleviate gene therapy capacity crunchGo to article: Q&A: ‘Trial failure due to recruitment is a thing of the past thanks to AI’ Go to article: NatoliGo to article: Pfeiffer VacuumGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue